Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results. J of Skin [Internet]. 2017 Oct. 27 [cited 2026 Apr. 19];1(3.1):s102. Available from: https://skin.dermsquared.com/skin/article/view/177